MorphoSys Analyst Ratings
MorphoSys Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/13/2023 | 41.32% | Morgan Stanley | $3.7 → $9.2 | Upgrades | Underweight → Overweight |
| 09/15/2023 | 42.09% | Goldman Sachs | $3.5 → $9.25 | Upgrades | Sell → Neutral |
| 06/22/2023 | 130.41% | JMP Securities | → $15 | Reiterates | Market Outperform → Market Outperform |
| 06/16/2023 | 161.14% | Wells Fargo | → $17 | Initiates Coverage On | → Overweight |
| 06/16/2023 | 53.61% | JP Morgan | $3.3 → $10 | Upgrades | Underweight → Overweight |
| 01/03/2023 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 11/18/2022 | 130.41% | JMP Securities | $32 → $15 | Maintains | Market Outperform |
| 01/14/2022 | — | Morgan Stanley | Downgrades | Overweight → Equal-Weight | |
| 08/06/2021 | — | Deutsche Bank | Downgrades | Buy → Hold | |
| 06/11/2021 | 268.66% | JP Morgan | $32 → $24 | Downgrades | Overweight → Neutral |
| 06/03/2021 | — | Bryan Garnier | Downgrades | Buy → Neutral | |
| 06/03/2021 | — | SVB Leerink | Upgrades | Market Perform → Outperform | |
| 05/24/2021 | 330.11% | Morgan Stanley | → $28 | Upgrades | Equal-Weight → Overweight |
| 03/23/2021 | — | SVB Leerink | Downgrades | Outperform → Market Perform | |
| 11/25/2020 | — | Morgan Stanley | Initiates Coverage On | → Equal-Weight | |
| 11/20/2019 | — | Guggenheim | Initiates Coverage On | → Buy | |
| 11/14/2018 | 422.27% | JP Morgan | $32 → $34 | Maintains | Overweight |
| 11/05/2018 | 483.72% | Piper Sandler | → $38 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 2023年10月13日 | 41.32% | 摩根士丹利 | $3.7→$9.2 | 升级 | 减持→超重 |
| 2023/09/15 | 42.09% | 高盛 | $3.5→$9.25 | 升级 | 卖出→中性 |
| 2023/06/22 | 130.41% | JMP证券 | →$15 | 重申 | 市场表现优于→市场表现 |
| 06/16/2023 | 161.14% | 富国银行 | →$17 | 开始承保 | →超重 |
| 06/16/2023 | 53.61% | 摩根大通 | $3.3→$10 | 升级 | 减持→超重 |
| 01/03/2023 | - | 摩根大通 | 评级下调 | 中性→减持 | |
| 2022年11月18日 | 130.41% | JMP证券 | $32→$15 | 维护 | 市场表现强于大盘 |
| 2022年01月14日 | - | 摩根士丹利 | 评级下调 | 超重→等重 | |
| 08/06/2021 | - | 德意志银行 | 评级下调 | 购买→Hold | |
| 2021/11/06 | 268.66% | 摩根大通 | $32→$24 | 评级下调 | 超重→中性 |
| 06/03/2021 | - | 布莱恩·加尼耶 | 评级下调 | 购买→中性 | |
| 06/03/2021 | - | SVB Leerink | 升级 | 市场表现优于→ | |
| 2021/05/24 | 330.11% | 摩根士丹利 | →$28 | 升级 | 等重→超重 |
| 03/23/2021 | - | SVB Leerink | 评级下调 | 跑赢→市场表现 | |
| 11/25/2020 | - | 摩根士丹利 | 开始承保 | →等重 | |
| 2019年11月20日 | - | 古根海姆 | 开始承保 | →购买 | |
| 2018年11月14日 | 422.27% | 摩根大通 | $32→$34 | 维护 | 超重 |
| 2018年11月05日 | 483.72% | 派珀·桑德勒 | →$38 | 开始承保 | →超重 |
What is the target price for MorphoSys (MOR)?
MorPhoSys(MOR)的目标价是多少？
The latest price target for MorphoSys (NASDAQ: MOR) was reported by Morgan Stanley on October 13, 2023. The analyst firm set a price target for $9.20 expecting MOR to rise to within 12 months (a possible 41.32% upside). 7 analyst firms have reported ratings in the last year.
摩根士丹利于2023年10月13日报道了Morphesys(纳斯达克：MOR)的最新目标价。这家分析公司将目标价定为9.20美元，预计MOR将在12个月内上涨(可能上涨41.32%)。去年有7家分析公司公布了评级。
What is the most recent analyst rating for MorphoSys (MOR)?
Morphesys(MOR)的最新分析师评级是多少？
The latest analyst rating for MorphoSys (NASDAQ: MOR) was provided by Morgan Stanley, and MorphoSys upgraded their overweight rating.
纳斯达克(Sequoia Capital：MOR)最新分析师评级由摩根士丹利提供，MorphSys上调其增持评级。
When is the next analyst rating going to be posted or updated for MorphoSys (MOR)?
MorPhoSys(MOR)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MorphoSys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MorphoSys was filed on October 13, 2023 so you should expect the next rating to be made available sometime around October 13, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查看公开的财务报表，与MorPhoSys的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。MorPhoSys的上一次评级是在2023年10月13日提交的，所以你应该预计下一次评级将在2024年10月13日左右的某个时候提供。
Is the Analyst Rating MorphoSys (MOR) correct?
分析师对MorPhoSys(MOR)的评级正确吗？
While ratings are subjective and will change, the latest MorphoSys (MOR) rating was a upgraded with a price target of $3.70 to $9.20. The current price MorphoSys (MOR) is trading at is $6.51, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但MorPhoSys(MOR)的最新评级被上调，目标价从3.70美元上调至9.20美元。MorPhoSys(MOR)目前的交易价格为6.51美元，在分析师的预测范围内。